Drug Abuse and Alcoholism Flashcards

A CMV driver presents for recertification and discloses they completed an inpatient alcohol rehabilitation program 14 months ago and have maintained documented sobriety since. Under 49 CFR 391.41(b)(13), which factor is MOST determinative of the medical examiner's certification decision?

Answer: Whether the driver currently meets the clinical criteria for an alcohol use disorder diagnosis, regardless of treatment history

49 CFR 391.41(b)(13) disqualifies drivers who have a 'current clinical diagnosis of alcoholism.' The regulation hinges on the word 'current.' A prior history of alcohol use disorder followed by successful treatment and sustained remission does not automatically disqualify — the ME must evaluate whether a current clinical diagnosis exists at the time of examination. Neither a mandatory sobriety duration, employer reinstatement, nor a physician clearance letter substitutes for this independent clinical assessment.

A driver with a current Schedule II opioid prescription (oxycodone for chronic low back pain) presents for a DOT physical. The prescribing physician has submitted a letter stating the driver tolerates the medication well. The FMCSA-certified medical examiner's MOST appropriate action is:

Answer: Evaluate whether the underlying pain condition, the opioid's side-effect profile, and evidence of impairment individually or collectively compromise safe driving

FMCSA regulations do not create a blanket disqualification for all Schedule II opioids. The medical examiner must conduct an individualized assessment: Does the underlying condition causing pain impair driving? Does the opioid itself (sedation, reaction time, cognitive effects) impair driving? Is there evidence of misuse or dependency? A physician's tolerance letter informs but does not override the ME's independent clinical judgment. MROs handle drug test results, not prescription review.

A CMV driver holds a valid state-issued medical marijuana card in a state where cannabis is legal. A pre-employment DOT urine drug screen returns a confirmed THC-COOH positive at 18 ng/mL (above the 15 ng/mL MRO confirmation threshold). The driver argues the result reflects lawful medical use. Which of the following correctly states the medical examiner's and MRO's obligations?

Answer: The MRO must report the result as positive; cannabis remains a Schedule I substance federally, and state authorization provides no DOT exception

Marijuana is a Schedule I controlled substance under federal law. DOT's drug and alcohol testing regulations (49 CFR Part 40) operate under federal law, and the MRO has no authority to verify a state-issued medical marijuana authorization as a legitimate medical explanation for a positive THC result. Unlike Schedule II–V medications, no state-level authorization can convert a positive marijuana test to a negative under DOT rules. The SAP referral requirement is triggered after a positive result is transmitted to the employer, not before the MRO issues its determination.

During a DOT physical, a driver discloses current use of buprenorphine/naloxone (Suboxone) prescribed by a licensed addiction medicine physician for opioid use disorder (OUD) maintenance. The driver has been stable on this regimen for 11 months with no relapses. What is the FMCSA's current regulatory position on this driver's certification eligibility?

Answer: The driver is disqualified primarily because the underlying opioid use disorder — an active substance use disorder — is itself disqualifying under 49 CFR 391.41(b)(12)

While buprenorphine itself is not explicitly named as a categorical disqualifier in the same way as methadone maintenance historically has been, the underlying condition — an active opioid use disorder — disqualifies under 49 CFR 391.41(b)(12), which prohibits certification of any person who 'uses a controlled substance' or who has been 'diagnosed as a current user.' A driver in OUD maintenance therapy has a documented current substance use disorder, regardless of the stability of treatment. The ME's analysis focuses on the disorder, not just the medication. FMCSA does not recognize OUD maintenance therapy as equivalent to full remission for CMV certification purposes.

A driver who previously failed a DOT random alcohol test (BAC 0.06%) has completed SAP evaluation and a prescribed follow-up treatment plan. The driver's follow-up testing file shows 8 unannounced alcohol tests over 18 months, all negative. The driver now seeks recertification from a new FMCSA-certified medical examiner who has not seen the driver before. Which statement BEST describes the ME's responsibility?

Answer: The ME must independently evaluate the driver's current fitness for duty, including assessing for any current alcohol use disorder, regardless of the SAP compliance history

The SAP process (return-to-duty and follow-up testing) is an employer/FMCSA compliance mechanism managed separately from the medical certification process. The medical examiner's role is to evaluate current medical fitness under 49 CFR 391.41. A driver who has completed SAP follow-up is not automatically medically certified — nor is one precluded. The ME must conduct a standard clinical assessment, including evaluating whether a current clinical diagnosis of alcoholism exists. SAP compliance history is informative context but does not replace the ME's independent determination. There is no mandated shortened certificate duration solely due to a prior alcohol violation.

A 52-year-old CDL applicant reports drinking 2–3 glasses of wine nightly for the past 6 years, which he describes as 'relaxing after work.' He denies any DUI arrests, job problems, or withdrawal symptoms. His ALT is mildly elevated at 58 U/L. His AUDIT-C score is 6. He does not meet full DSM-5 criteria for alcohol use disorder based on history. Under FMCSA standards, which approach is MOST clinically defensible?

Answer: Decline to certify pending further evaluation, as the pattern of daily alcohol use, elevated hepatic enzyme, and high AUDIT-C score together suggest a risk profile warranting specialist assessment before certification

While the driver does not formally meet DSM-5 AUD criteria, the clinical picture — habitual daily alcohol consumption at a quantity consistent with hazardous use, an AUDIT-C score of 6 (threshold for hazardous use in males is ≥4), and mildly elevated ALT suggesting hepatic involvement — raises legitimate concerns about borderline alcohol-related impairment risk. FMCSA guidance expects the ME to assess not just diagnostic thresholds but overall risk to public safety. Certifying based solely on absence of a formal DSM-5 diagnosis ignores the totality of findings. Elevated ALT alone is not an independent categorical disqualifier, but it contributes to clinical concern. The 4-hour rule applies to on-duty abstinence, not as a substitute for addressing an ongoing pattern of heavy use.